ApoE genotype and cardiovascular risk biomarkers: impact of gender and BMI (the FINGEN Study)
ApoE genotype and cardiovascular risk biomarkers: impact of gender and BMI (the FINGEN Study)
About this item
Full title
Author / Creator
Publisher
Cambridge, UK: Cambridge University Press
Journal title
Language
English
Formats
Publication information
Publisher
Cambridge, UK: Cambridge University Press
Subjects
More information
Scope and Contents
Contents
The FINGEN intervention trial (n 312; mean age 45 (sd 1) years and BMI 25.2 (sd 0.2) kg/m2) examined the impact of age, gender and apoE genotype (with prospective recruitment on the basis of these variables) on the response of over forty established and putative CHD risk indicators to modest-dose fish oil intake.
Alternative Titles
Full title
ApoE genotype and cardiovascular risk biomarkers: impact of gender and BMI (the FINGEN Study)
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_journals_227375535
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_227375535
Other Identifiers
ISSN
0029-6651
E-ISSN
1475-2719
DOI
10.1017/S0029665109992084
